Strategy and targets
Aiforia aims to revolutionize pathology with AI to provide better care for every patient. The company's vision is to be the global leader in AI-powered pathology image analysis.
Aiforia’s growth is supported by megatrends such as rising rates of cancer and chronic diseases, aging populations, and personalized healthcare, which are driving up sample volumes at a time when certain geographic areas are experiencing a shortage of pathologists.
GROWTH
Invest in sales, marketing, and support services in the US, Europe, and other key markets to enable strong growth. Scale the business by acquiring new customers, increasing sales within individual accounts, and establishing key strategic partnerships.
PRODUCT
Invest in R&D to strengthen our competitive advantage (AI-driven workflow, transparency, a versatile portfolio, and security) and continue developing features to further improve the customer experience. Adopt new regulatory frameworks in key markets.
PEOPLE
Invest in people management to improve employee experience and personnel productivity. Leverage our purpose-driven culture to attract and retain top-tier talent.
Aiforia does not publish short-term outlooks or financial targets. However, the company has set medium-term business targets:
Aiforia’s mid-term business targets:

Megatrends

AI transformation

Cloud adaptation in healthcare

Aging population

Personalized healthcare

Rising healthcare costs

Shortage of pathologists